Overview
Weilie Xiao practices practicing medicine in Kunming, China.
Their clinical expertise encompasses Togaviridae Disease, Methicillin-Resistant Staphylococcus Aureus (MRSA), Rubella, and Liver Cancer.
They are actively involved in clinical research, co-authoring 33 peer reviewed articles.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Frequently Asked Questions about Weilie J. Xiao
Is Weilie J. Xiao a top-rated expert for Togaviridae Disease?
MediFind is an objective health platform that identifies experts based on real-world data. Weilie J. Xiao is classified as an Experienced expert for Togaviridae Disease, meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
Does Weilie J. Xiao participate in research or clinical trials?
Yes. Weilie J. Xiao has published 33 articles and abstracts on conditions like Togaviridae Disease. You can view a list of Weilie J. Xiao's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Liver CancerXiao isExperienced. Learn about Liver Cancer.
- Methicillin-Resistant Staphylococcus Aureus (MRSA)
- RubellaXiao isExperienced. Learn about Rubella.
- Togaviridae DiseaseXiao isExperienced. Learn about Togaviridae Disease.